Work

Self-Assembled Peptide PROTAC Prodrugs Targeting FOXM1 for Cancer Therapy

Year: 2025

Type: article

Source: Molecular Pharmaceutics

DOI: 10.1021/acs.molpharmaceut.5c00219

Authors: Huajie Zeng, Zhiguo Fang, Yinghua Feng, Tong Su, Weibing Miao, Zihua Wang

Institutions: Fujian Medical University, National Center for Nanoscience and Technology, Shanxi Medical University, First Affiliated Hospital of Fujian Medical University

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province

Awards: G1066295578, G4375968759, G6177454517

OpenAlex ID: W4410354972

FWCI: 3.527

Cites: 38

Cited by: 14

Related to: 10